| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 658855 | Null | 0.0219468083770723 | 0.052561638 |
| NSC 679240 | Null | 0.0219468083770723 | -0.11252746 |
| NSC 689626 | Null | 0.0219468083770723 | -0.12196773 |
| NSC 693037 | Null | 0.0219468083770723 | 0.10504701 |
| NSC 693169 | Null | 0.0219468083770723 | 0.16886558 |
| NSC 699934 | Null | 0.0219468083770723 | 0.079207043 |
| NSC 709358 | 1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol | 0.0219468083770723 | -0.018381844 |
| NSC 718564 | Null | 0.0219468083770723 | 0.032708317 |
| NSC 727620 | 6-[3-(2-Aminoethylamino)]-bis{1-propyl)-5,6-dihydro-2,3-dime thoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquin oline} dihydrochloride | 0.0219468083770723 | 0.25879669 |
| NSC 730009 | cis-2,5,6,12,13-Pentahydro-6-methyl-(8,9-methylenedioxy)-3-n itro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline | 0.0219468083770723 | 0.11311431 |